Sputnik Light / Gamaleya Research Institute 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Sputnik Light / Gamaleya Research Institute
SPUTNIK-LIGHT, NCT04741061: Study to Evaluate Efficacy, Immunogenicity and Safety of the Sputnik-Light

Recruiting
3
6000
RoW
Sputnik Light, Placebo
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation, RDIF (Russian Direct Investment Fund), CRO: iPharma, Government of the city of Moscow
COVID-19 Prevention
12/21
01/22
NCT04713488: An Open Study on the Safety, Tolerability, and Immunogenicity of "Sputnik Light" Vaccine

Active, not recruiting
1/2
110
RoW
Sputnik Light, vector vaccine to help prevent the SARS-CoV-2-induced coronavirus infection
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation, RDIF (Russian Direct Investment Fund)
COVID-19 Prevention
07/21
07/21

Download Options